Skip to main content
Category

News Archive

us-sba-logoa

America’s Seed Fund: How the SBIR/STTR Programs Help Enable Catalytic Growth and Technological Advances

By News Archive

us-sba-logoa

In order for America to maintain its innovative and technological competitive advantage, it is imperative that current policy design favor high growth formation through the catalytic means of institutional financing. The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs have historically served as crucial financing to help de-risk early-stage technology development and enable validation that encourages follow-on private institution capitalization. With new trends in the Internet of Things, artificial intelligence, advanced materials, genomics, environmental sustainability, renewable energy, national security, and many other areas evolving over the years ahead, national governments bear the responsibility for helping seed the inventive fire that enables economic growth as we move forward.

Read More
small-biz-cyber-security-summit-logo

SBCX Spring Summit 2017

By News Archive

small-biz-cyber-security-summit-logo

WEDNESDAY, APRIL 19, 2017, 8:30 AM – 12 PM | WASHINGTON, DC

If you do business with the government, you are a target for cyber-attacks!

If you are a government contractor, join us to learn how to implement a strong and cost effective cybersecurity program that will strengthen your company’s cybersecurity posture and help you meet requirements necessary to do business with the federal government. As an attendee, you can receive two customized assessments to help identify your company’s level of exposure: (1) a mini cyber-risk review from CyberRx that will assess your company’s cyber capabilities within the Cybersecurity Framework; and (2) a threat intelligence assessment from Wapack Labs that can help to identify if your organization has been or will be the victim of an attack. Space is limited. Register today.

Read More

Pulmocide Raises $30.4M for Clinical Development of Inhaled Respiratory Drugs – GEN

By News Archive

	
Pulmocide-logo

Pulmocide raised $30.4 million in a Series B round of financing to support the early clinical development of its lead inhaled drugs against respiratory syncytial virus (RSV) and pulmonary aspergillosis. The fundraising round was led by new investor SR One and included the Longwood Fund and existing investors SV Life Sciences, F-Prime Capital, Johnson & Johnson Innovation–JJDC, and Touchstone Innovations.

Read More
university-of-maryland-university-college-umuc-logo

U of Maryland University College pursues strategy of ‘unbundling’

By News Archive

university-of-maryland-university-college-umuc-logo

The University of Maryland University College is tearing itself apart — on purpose.

The university, which gets nearly all of its funding from tuition revenue, has long relied on enrolling large numbers of students associated with the military for financial stability. After teaching students at military bases across Asia and Europe for decades, the university was quick to realize the potential of the internet and became a pioneer in the field of distance education.

Read More
maryland tech council logo

Financial Executives Forum Breakfast – Raising Capital in Today’s Economy

By News Archive

Friday, April 14, 2017 7:30 AM – 9:30 AM

Bethesda Marriott – 5151 Pooks Hill Road Bethesda, MD 20814

maryland-tech-council-logo

With the transition to the Trump administration, change is coming rapidly in the form of legislative proposals, regulations (or repeal thereof), and policy statements. How will all this affect the ability of tech companies to raise the capital they need to grow. Amid this shifting ground, we’ve asked an expert panel of our own Maryland technology companies to talk about their recent successes and challenges in raising capital and their outlook for the ability of Maryland technology companies to do the same. Our panel, moderated by David Straut of Wells Fargo, includes two long-time local tech CFOs who have had recent success raising money and the Director of the Maryland Venture Fund, which oversees investments in approximately 50 local technology ventures

Financial Executives Forum: FEF is devoted to peer-to-peer connections and programs that highlight the latest topics of interest for the region’s leading business and financial executives. FEF encourages participants to connect as well as learn from some of the area’s preeminent executives, policymakers and thought leaders.

Read More
Maryland map flag

There was a Final Four for tech transfer and Maryland dominated – Technical.ly Baltimore

By News Archive

Maryland map flag

Newsflash: The Association of University Technology Managers met in Hollywood, Fla., and had its own Final Four last week.

All of the finalists of the conference’s pitch competition had a common bond: They each had ties to Maryland universities such as Johns Hopkins and University of Maryland. All four also received funding from TEDCO’s Maryland Innovation Initiative.

Read More
chacon-marco-umb-image

University of Maryland, Baltimore Appoints BioPharma Industry Veteran Marco Chacón as Assistant VP, Industry Alliances – UM BioPark

By News Archive

chacon-marco-umb-image

The University of Maryland, Baltimore (UMB) today announced the appointment of Marco Chacón, PhD, as Assistant Vice President, Industry Alliances. In this role, Dr. Chacón, a seasoned biopharmaceutical executive and entrepreneur, will work with the Office of Research and Development, UM Ventures, and University of Maryland BioPark teams, leading special projects to grow the BioPark tenant base and strengthen the University’s research collaborations with industry.

 “Marco is a distinguished scientist, entrepreneur, and biopharma CEO who has spent many years working as a valued member of the UM BioPark community,” said James L. Hughes, Vice President and Chief Enterprise & Economic Development Officer and president of the corporation that manages the UM BioPark. “His accomplishments leading a successful contract development and manufacturing organization, along with his deep industry and government connections, make him a superb addition to our team at UMB.

Read More
PHARMARON-logo

Pharmaron Acquires Majority Stake in SNBL CPC – UM BioPark

By News Archive

PHARMARON-logo

Pharmaron, a fully integrated contract research organization offering R&D services to the life sciences industry, today announced that it has signed a definitive agreement under which Pharmaron will acquire a majority stake in Shin Nippon Biomedical Laboratories Clinical Pharmacology Center, Inc. (“SNBL CPC”) in Baltimore, Maryland, USA. This clinical center is a leading provider of moderate and highly complex Phase I/II clinical development services for the life sciences sector. Current shareholder Shin Nippon Biomedical Laboratories, Ltd. (SNBL) (TSE:2395) will retain a minority stake in the business following the transaction.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.